Administration of OKT3 as a two-hour infusion does not attenuate first- dose side effects [2]

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)709-710
Number of pages2
JournalTransplantation
Volume68
Issue number5
DOIs
StatePublished - Sep 15 1999

Cite this